These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 9927189)
21. Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder. Chikazawa M; Inoue K; Fukata S; Karashima T; Shuin T Pathobiology; 2008; 75(6):335-45. PubMed ID: 19096229 [TBL] [Abstract][Full Text] [Related]
22. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy. Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652 [TBL] [Abstract][Full Text] [Related]
23. Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo. Krutovskikh VA; Troyanovsky SM; Piccoli C; Tsuda H; Asamoto M; Yamasaki H Oncogene; 2000 Jan; 19(4):505-13. PubMed ID: 10698520 [TBL] [Abstract][Full Text] [Related]
24. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR. Wang X; Weng LP; Yu Q Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis. Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141 [TBL] [Abstract][Full Text] [Related]
26. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174 [TBL] [Abstract][Full Text] [Related]
27. The role of fibroblast growth factors and their receptors in prostate cancer. Kwabi-Addo B; Ozen M; Ittmann M Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447 [TBL] [Abstract][Full Text] [Related]
28. Differential regulation of cell growth and gene expression by FGF-2 and FGF-4 in pituitary lactotroph GH4 cells. Jackson TA; Koterwas DM; Bradford AP Mol Cell Endocrinol; 2006 Mar; 247(1-2):183-91. PubMed ID: 16469431 [TBL] [Abstract][Full Text] [Related]
29. Fibroblast-dependent tumorigenicity of cells in nude mice: implication for implantation of metastases. Picard O; Rolland Y; Poupon MF Cancer Res; 1986 Jul; 46(7):3290-4. PubMed ID: 3708562 [TBL] [Abstract][Full Text] [Related]
30. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis. Hajitou A; Sounni NE; Devy L; Grignet-Debrus C; Lewalle JM; Li H; Deroanne CF; Lu H; Colige A; Nusgens BV; Frankenne F; Maron A; Yeh P; Perricaudet M; Chang Y; Soria C; Calberg-Bacq CM; Foidart JM; Noël A Cancer Res; 2001 Apr; 61(8):3450-7. PubMed ID: 11309307 [TBL] [Abstract][Full Text] [Related]
31. A role for extracellular and transmembrane domains of Sef in Sef-mediated inhibition of FGF signaling. Kovalenko D; Yang X; Chen PY; Nadeau RJ; Zubanova O; Pigeon K; Friesel R Cell Signal; 2006 Nov; 18(11):1958-66. PubMed ID: 16603339 [TBL] [Abstract][Full Text] [Related]
33. Comparison of invasiveness and non-invasiveness of two epithelial cell lines in vitro. Schroyens W; Bruyneel R; Tchao R; Leighton J; Dragonetti C; Mareel M Invasion Metastasis; 1984; 4(3):160-70. PubMed ID: 6480288 [TBL] [Abstract][Full Text] [Related]
34. Epithelial cell plasticity in development and tumor progression. Thiery JP; Chopin D Cancer Metastasis Rev; 1999; 18(1):31-42. PubMed ID: 10505544 [TBL] [Abstract][Full Text] [Related]
35. Targets of fibroblast growth factor 1 (FGF-1) and FGF-2 signaling involved in the invasive and tumorigenic behavior of carcinoma cells. Billottet C; Elkhatib N; Thiery JP; Jouanneau J Mol Biol Cell; 2004 Oct; 15(10):4725-34. PubMed ID: 15282342 [TBL] [Abstract][Full Text] [Related]
36. A minority of carcinoma cells producing acidic fibroblast growth factor induces a community effect for tumor progression. Jouanneau J; Moens G; Bourgeois Y; Poupon MF; Thiery JP Proc Natl Acad Sci U S A; 1994 Jan; 91(1):286-90. PubMed ID: 7506417 [TBL] [Abstract][Full Text] [Related]
37. Different invasion capacity of NBT II and MDCK in the chick embryo chorioallantois. Schroyens W; Schroyens E; Bielunas J Anticancer Res; 1989; 9(6):1665-8. PubMed ID: 2627119 [TBL] [Abstract][Full Text] [Related]
38. Effect of transfected interleukin-6 in non-tumorigenic and tumorigenic rat urothelial cell lines. Okamoto M; Oyasu R Int J Cancer; 1996 Nov; 68(5):616-21. PubMed ID: 8938144 [TBL] [Abstract][Full Text] [Related]
39. FGF-1 but not FGF-4 secreted by carcinoma cells promotes in vitro and in vivo angiogenesis and rapid tumor proliferation. Jouanneau J; Moens G; Montesano R; Thiery JP Growth Factors; 1995; 12(1):37-47. PubMed ID: 8527162 [TBL] [Abstract][Full Text] [Related]
40. Acidic fibroblast growth factor is a modulator of epithelial plasticity in a rat bladder carcinoma cell line. Vallés AM; Boyer B; Badet J; Tucker GC; Barritault D; Thiery JP Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1124-8. PubMed ID: 2153969 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]